Species | Target name | Source | Bibliographic reference |
---|---|---|---|
Homo sapiens | malonyl-CoA decarboxylase | Starlite/ChEMBL | References |
Species | Potential target | Raw | Global | Species |
---|---|---|---|---|
Giardia lamblia | Kinase, CMGC GSK | 0.0057 | 0 | 0.5 |
Trichomonas vaginalis | CMGC family protein kinase | 0.0057 | 0 | 0.5 |
Plasmodium vivax | glycogen synthase kinase 3, putative | 0.0057 | 0 | 0.5 |
Leishmania major | malonyl-coa decarboxylase-like protein | 0.0198 | 0.316 | 1 |
Trypanosoma brucei | malonyl-CoA decarboxylase, mitochondrial precursor, putative | 0.0198 | 0.316 | 1 |
Giardia lamblia | Kinase, CMGC GSK | 0.0057 | 0 | 0.5 |
Onchocerca volvulus | 0.0057 | 0 | 0.5 | |
Trypanosoma cruzi | malonyl-CoA decarboxylase, mitochondrial precursor, putative | 0.0198 | 0.316 | 1 |
Trichomonas vaginalis | CMGC family protein kinase | 0.0057 | 0 | 0.5 |
Entamoeba histolytica | protein kinase, putative | 0.0057 | 0 | 0.5 |
Trypanosoma cruzi | malonyl-CoA decarboxylase, mitochondrial precursor, putative | 0.0198 | 0.316 | 1 |
Entamoeba histolytica | protein kinase domain containing protein | 0.0057 | 0 | 0.5 |
Echinococcus granulosus | protein kinase shaggy | 0.0057 | 0 | 0.5 |
Plasmodium falciparum | glycogen synthase kinase 3 | 0.0057 | 0 | 0.5 |
Entamoeba histolytica | protein kinase domain containing protein | 0.0057 | 0 | 0.5 |
Echinococcus granulosus | glycogen synthase kinase 3 beta | 0.0057 | 0 | 0.5 |
Loa Loa (eye worm) | hypothetical protein | 0.0504 | 1 | 1 |
Wolbachia endosymbiont of Brugia malayi | malonyl-CoA decarboxylase | 0.0504 | 1 | 0.5 |
Echinococcus multilocularis | glycogen synthase kinase 3 beta | 0.0057 | 0 | 0.5 |
Toxoplasma gondii | cell-cycle-associated protein kinase GSK, putative | 0.0057 | 0 | 0.5 |
Schistosoma mansoni | glycogen synthase kinase 3-related (gsk3) (cmgc group III) | 0.0057 | 0 | 0.5 |
Echinococcus multilocularis | protein kinase shaggy | 0.0057 | 0 | 0.5 |
Many chemical entities in TDR Targets come from high-throughput screenings with whole cells or tissue samples, and not all assayed compounds have been tested against a single a single target protein, probably because they get ruled out during screening process. Even if these compounds may have not been of interest in the original screening, they may come as interesting leads for other screening assays. Furthermore, we may be able to propose drug-target associations using chemical similarities and network patterns.
1 literature reference was collected for this gene.